LONDON, Nov. 30, 2016 /PRNewswire/ -- The high-throughput screening (HTS) market is expected to grow at a lucrative CAGR of 7.8% from 2016 to 2021, to reach USD 18.83 billion by 2021 from USD 12.23 billion in 2016. Market growth can be attributed to the growing adoption of open innovative models in the pharmaceutical and biotechnology industry and technological advancements like automation and miniaturization, increasing R&D spending and rising government funding. Emerging markets and growing research activities in toxicology and stem cells provide significant growth opportunities for the market. On the other hand, the high cost and time-consuming nature of HTS techniques are restraining the growth of this market during the forecast period.
The global high-throughput screening market is segmented on the basis of product and service, technology, application end user and region. Based on product and service, the high-throughput screening market is segmented into consumables and reagents, instruments, & software and services. Based on technology, the high-throughput screening market is segmented into cell-based assays; lab-on-a-chip, ultra high-throughput screening market, label-free technology and bioinformatics. The cell-based assays segment is subsegmented into 2D cell culture, 3D cell culture and perfusion cell culture. 3D cell culture is further divided into scaffold-based technology (includes hydrogels and inert matrix/solid scaffolds segment) and scaffold-free technology (includes microplates, hanging-drop plates, ultra-low binding plates and others segment).
The hydrogels scaffold-based technology is further subsegmented into animal-derived (includes matrigel and collagen segment), agarose/alginate and synthetic hydrogels. The other scaffold-free technology segment includes microfluidics, 3D bioreactors & magnetic levitation, and 3D bioprinting. Based on application, the HTS market is segmented into target identification, primary screening, toxicology assessment and others. The other application segment includes hospitals and clinical laboratories, food and agriculture industries, & environmental laboratories. Based on the end users, the market is classified into pharmaceutical and biotechnology companies, academic and government research institutes, contract research organizations (CROs) and other end users. The other end users segment includes hospitals & clinics, and food, agriculture, and environmental industries.
Geographically, North America is the largest market for high-throughput screening, followed by Europe and Asia-Pacific. However, Asia-Pacific and Latin America possess lucrative growth potential for the high-throughput screening market during the forecast period. This is mainly attributed to the increasing R&D spending; growing trend of outsourcing drug discovery services; growing public-private partnerships; and increasing government funding.
The high-throughput screening market is fragmented in nature with the presence of many small and big firms. The major players in the high-throughput screening market include Agilent Technologies, Inc. (U.S.), Danaher Corporation (U.S.), Thermo Fisher Scientific, Inc. (U.S.), PerkinElmer, Inc. (U.S.) and Tecan Group Ltd. (Switzerland), Merck Millipore (U.S.), Bio-Rad laboratories (U.S.), Hamilton Company (U.S.), Axxam S.p.A. (Italy) and Aurora Biomed (Canada).
The high-throughput screening market in this report is segmented by product and service, application, technology, end user, and regions. It provides detailed information regarding major factors influencing the growth market (drivers, restraints, opportunities, and trends). The study tracks and analyzes competitive developments such as partnerships, agreements, collaborations, acquisitions, new product developments, geographical expansions, and strategically profiles the key players and comprehensively analyzes their market shares and core competencies in the high-throughput screening market
Reasons to buy this report:
From an insight perspective, this research report has focused on various levels of analysis—industry analysis (industry trends), market share analysis of top players, and company profiles, which together comprise and discuss the basic views on the competitive landscape; emerging and high-growth segments of the high-throughput screening market; high-growth regions; and market drivers, restraints, trends, and opportunities.
The report provides insights on the following pointers:
- Market Penetration: Comprehensive information on portfolios offered by the top players in the global high-throughput screening market. The report analyzes the high-throughput screening market by technology, application, products and services, and end users across all the regions.
- Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product launches in the high-throughput screening market
- Market Development: Comprehensive information about lucrative emerging markets – the report analyzes the markets for high-throughput screening across regions
- Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the global high-throughput screening market
- Competitive Assessment: In-depth assessment of market shares, strategies, products, and manufacturing capabilities of the leading players in the global high-throughput screening market
Download the full report: https://www.reportbuyer.com/product/4405157/
Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers
For more information:
Research Advisor at Reportbuyer.com
Email: [email protected]
Tel: +44 208 816 85 48